These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38087652)

  • 21. Impact of hospital environmental cleaning with a potassium peroxymonosulphate-based environmental disinfectant and antimicrobial stewardship on the reduction of hospital-onset Clostridioides difficile infections.
    Umemura T; Mutoh Y; Maeda M; Hagihara M; Ohta A; Mizuno T; Kato H; Sukawa M; Yamada T; Ikeda Y; Mikamo H; Ichihara T
    J Hosp Infect; 2022 Nov; 129():181-188. PubMed ID: 35820556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between antiulcer agents and Clostridioides difficile infection in patients receiving antibiotics: A retrospective cohort study using the diagnosis procedure combination database in Japan.
    Ishida R; Seki T; Kawakami K
    Anaerobe; 2022 Jun; 75():102537. PubMed ID: 35202792
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Ötleş E; Balczewski EA; Keidan M; Oh J; Patel A; Young VB; Rao K; Wiens J
    Infect Control Hosp Epidemiol; 2023 Nov; 44(11):1776-1781. PubMed ID: 37088695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comorbidity and severity-of-illness risk adjustment for hospital-onset
    Cabral SM; Goodman KE; Blanco N; Leekha S; Magder LS; Nadimpalli G; Pineles L; Thom KA; Harris AD
    Infect Control Hosp Epidemiol; 2021 Aug; 42(8):955-961. PubMed ID: 33327970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences in time-to-testing and time-to-isolation between community-onset and hospital-onset Clostridioides difficile cases at a tertiary care VA medical center.
    Hostler CJ; Bertumen JB; Park LP; Wilkins SB; Woods CW
    Am J Infect Control; 2020 Oct; 48(10):1148-1151. PubMed ID: 31911067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessing risk factors, mortality, and healthcare utilization associated with Clostridioides difficile infection in four Latin American countries.
    Yu H; Flaster N; Casanello AL; Curcio D
    Braz J Infect Dis; 2021; 25(1):101040. PubMed ID: 33290727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors Associated with Clostridioides (Clostridium) Difficile Infection and Colonization: Ongoing Prospective Cohort Study in a French University Hospital.
    Khanafer N; Vanhems P; Bennia S; Martin-Gaujard G; Juillard L; Rimmelé T; Argaud L; Martin O; Huriaux L; Marcotte G; Hernu R; Floccard B; Cassier P; Group S
    Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34299978
    [No Abstract]   [Full Text] [Related]  

  • 28. In pursuit of the holy grail: Improving
    Karlovich NS; Sata SS; Griffith B; Coop A; Kalu IC; Engemann JJ; Seidelman J; Turner NA; Polage CR; Smith BA; Lewis SS
    Infect Control Hosp Epidemiol; 2022 Jul; 43(7):840-847. PubMed ID: 34085622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Healthcare facility-onset, healthcare facility-associated
    Evans CT; Fitzpatrick M; Ramanathan S; Kralovic SM; Burns SP; Goldstein B; Smith B; Gerding DN; Johnson S
    J Spinal Cord Med; 2020 Sep; 43(5):642-652. PubMed ID: 31663843
    [No Abstract]   [Full Text] [Related]  

  • 30. Impact of the COVID-19 pandemic on the incidence of healthcare facility-onset Clostridioides difficile infection in hospitalized patients with sepsis: Interrupted time series analysis using Japanese Diagnosis Procedure Combination data.
    Endo K; Mizuno K; Takeuchi M; Kawakami K
    Anaerobe; 2023 Feb; 79():102693. PubMed ID: 36623703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surveillance and epidemiology of Clostridioides difficile infection using the national health surveillance network criteria: A 7-year study from Mumbai, India.
    Rohra S; Poojary A; Patil P; John S; Michael R; Johnson S; Pardeshi P
    Indian J Med Microbiol; 2023; 46():100425. PubMed ID: 37945118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Community Factors with Hospital-onset
    Zacharioudakis IM; Zervou FN; Shehadeh F; Mylona EK; Mylonakis E
    EClinicalMedicine; 2019 Feb; 8():12-19. PubMed ID: 31193719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessing the Impact of 2-Step Clostridioides difficile Testing at the Healthcare Facility Level.
    Turner NA; Krishnan J; Nelson A; Polage CR; Cochran RL; Fike L; Kuhar DT; Kutty PK; Snyder RL; Anderson DJ
    Clin Infect Dis; 2023 Oct; 77(7):1043-1049. PubMed ID: 37279965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Effect of Clostridioides difficile Diagnostic Stewardship Interventions on the Diagnosis of Hospital-Onset Clostridioides difficile Infections.
    Kang M; Abeles SR; El-Kareh R; Taplitz RA; Nyheim E; Reed SL; Jenkins IH; Seymann GB; Myers FE; Torriani FJ;
    Jt Comm J Qual Patient Saf; 2020 Aug; 46(8):457-463. PubMed ID: 32576438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of mandatory nucleic acid amplification test (NAAT) testing approval on hospital-onset
    McCormick WL; Jackson G; Andrea SB; Whitehead V; Chargualaf TL; Touzard-Romo F
    Infect Control Hosp Epidemiol; 2024 Jan; 45(1):106-109. PubMed ID: 37424227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterizing
    Magro M; Rosenberg J; Epson E
    Infect Control Hosp Epidemiol; 2021 Mar; 42(3):292-297. PubMed ID: 32993820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of hospital-onset Clostridioides difficile infection in children with antibiotic-associated diarrhea.
    Polat M; Tapısız A; Demirdağ TB; Yayla BC; Kara SS; Tezer H; Belet N; Çırak MY
    Am J Infect Control; 2023 Aug; 51(8):879-883. PubMed ID: 36535316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Costs Associated with the Treatment of Clostridioides Difficile Infections.
    Sierocka A; Kiersnowska Z; Lemiech-Mirowska E; Marczak M
    Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34300098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Saccharomyces boulardii prophylaxis for targeted antibiotics and infectious indications to reduce healthcare facility-onset Clostridioides difficile infection.
    Wombwell E
    Microbes Infect; 2023; 25(3):105041. PubMed ID: 36058513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implementation of a multidisciplinary process to improve diagnostic stewardship of hospital-onset Clostridioides difficile infections.
    Bussell C; Vincent J; Brust K
    Am J Infect Control; 2023 Dec; 51(12):1329-1333. PubMed ID: 37295677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.